IN VIVO EFFECTS OF EPRATUZUMAB, A MONOCLONAL ANTIBODY TARGETING HUMAN CD22, ON B CELL FUNCTION IN HUMAN CD22 KNOCK-IN (HUKI) MICE

Brandl C, Özgör L, Wöhner M, Shock A, Nitschke L (2014)

Publication Type: Conference contribution

Publication year: 2014

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: 811-811

Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES

Event location: Paris FR

DOI: 10.1136/annrheumdis-2014-eular.1751

Authors with CRIS profile

Carolin Brandl Professur für Genetik Lamia Özgör Professur für Genetik Miriam Wöhner Professur für Genetik Lars Nitschke Professur für Genetik

Involved external institutions

UCB Pharma Ltd GB United Kingdom (GB)

How to cite

APA:

Brandl, C., Özgör, L., Wöhner, M., Shock, A., & Nitschke, L. (2014). IN VIVO EFFECTS OF EPRATUZUMAB, A MONOCLONAL ANTIBODY TARGETING HUMAN CD22, ON B CELL FUNCTION IN HUMAN CD22 KNOCK-IN (HUKI) MICE. In ANNALS OF THE RHEUMATIC DISEASES (pp. 811-811). Paris, FR: LONDON: BMJ PUBLISHING GROUP.

MLA:

Brandl, Carolin, et al. "IN VIVO EFFECTS OF EPRATUZUMAB, A MONOCLONAL ANTIBODY TARGETING HUMAN CD22, ON B CELL FUNCTION IN HUMAN CD22 KNOCK-IN (HUKI) MICE." Proceedings of the 15th Annual European Congress of Rheumatology (EULAR), Paris LONDON: BMJ PUBLISHING GROUP, 2014. 811-811.

BibTeX: Download